life.made better.



Baxter Vaccines AG
Industriestraße 67
A-1221 Wien




  Find:      

Privacy Statement
Terms & Conditions

Prophylaxis

For many years, the WHO has provided consultation services to examine the current influenza virus strains circulating worldwide and has recommended the appropriate vaccine composition to be used for the following season. The WHO strongly supports and encourages vaccine research based on tissue cultures and other methodologies due to the limited stock of fertilized chicken eggs for vaccine production. In case of a pandemic, this will be a limiting factor for the success of worldwide immunization campaigns. Baxter's special attention is therefore focused on the development of modern production technologies for influenza vaccines, such serom proteinfree Vero cell technology like Vero cell lines.